Sunday, April 11, 2021
- Advertisement -
Home World Amnesty International has condemned rich countries' policies on COVID-19 vaccines

Amnesty International has condemned rich countries’ policies on COVID-19 vaccines


In its annual report, Amnesty emphasizes that the global health crises have brought “broken” practices to the forefront, and emphasized that the only way out is international cooperation.

“The pandemic has unpleasantly exposed the world’s inability to work together effectively and honestly,” said Agnes Callamard, Amnesty’s secretary general last month.

“The richest countries have effectively gained a near monopoly on global stocks of vaccines, leaving the least resource-rich countries to grapple with the worst health and human rights consequences,” she added.

Amnesty has strongly criticized former US President Donald Trump’s decision to withdraw Washington from the World Health Organization (WHO) during the COVID-19 pandemic, although his successor, Joe Biden, has reversed the move.

Mr Callamard called for an immediate acceleration of global vaccination efforts, calling them “the most essential, albeit rudimentary, test of the world’s ability to work together.”

Growing inequality

- Advertisement -

Since the end of 2019, when the new coronavirus was first detected in China, the pandemic has claimed more than 2.8 million lives. human lives. At least 130 million COVID-19s have been approved worldwide. people.

Although international organizations have regularly called on the world to show solidarity, the data show that inequalities between countries in terms of vaccines are growing.

According to AFP news agency statistics, more than half of the 680 million global injections of COVID-19 vaccines have been used in rich countries such as the United States, the United Kingdom, and Israel. The poorest countries have so far received only 0.1 percent. of this quantity.

In late March, the WHO warned of growing inequalities in the distribution of vaccines.

Amnesty International has supported initiatives such as the WHO Vaccine Information Sharing Program C-TAP.

The initiative has so far been used less than its capacity allows, increasing production capacity and expanding the network of vaccine manufacturers, especially in Africa, Asia and Latin America, the WHO stressed.

Amnesty has rejected “insignificant, incomplete” measures, such as the G20’s decision to freeze debt repayments for 77 countries.



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments